Perficient: Drug Development

MARCH 6, 2025

Welcome to our new series on Universal Design for Pharmacies! In this segment, well explore the importance of Universal Design in Pharmacies for All Disabilities. Pharmacies play a crucial role in the healthcare system, providing essential services to individuals from all walks of life. What is Universal Design?

Pharmacy 52

Pharmacy Production 52

Perficient: Drug Development

APRIL 17, 2025

Creating operable content in pharmacies that accommodates the diverse needs and preferences of all users is critical for accessibility. Pharmacies can use this principle to ensure that everyone, regardless of physical, cognitive, or sensory abilities, can engage comfortably with their services. What is Flexibility in Use?

Pharmacy 52

Pharmacy Production 52

Drug Channels

NOVEMBER 4, 2024

In contrast to the pharmacy market, adoption of these biosimilars is growing, prices are dropping, and formulary barriers continue to fall. What’s more, plans can pay hospitals more for a biosimilar than for the higher-cost reference product. As we demonstrate, health plans pay hospitals far above acquisition costs for biosimilars.

Biosimilars 98

Biosimilars Hospitals Pharmacy Drugs 98

Drug Channels

APRIL 8, 2022

He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment. To learn more about CoAssist and AssistRx specialty therapy initiation and patient support services, click here to schedule a meeting with AssistRx at the Asembia Specialty Pharmacy Summit on May 2-5, 2022.

Specialty Pharmacies 96

Specialty Pharmacies Production Pharmacy Therapies 96

Drug Channels

MAY 9, 2022

Informa Connect’s Hub and Specialty Pharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. For 2022 only, Hub and Specialty Pharmacy Models and PAP – Patient Assistance & Access Programs are under the same roof. Delivered as a Hybrid Event.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Pharmaceuticals Government 75

Perficient: Drug Development

APRIL 17, 2025

In pharmacies, this Universal Design principle ensures that services, tools, and spaces require minimal physical strain, allowing individuals with mobility limitations, chronic conditions, or temporary injuries to engage comfortably. For instance, touchscreens should be sensitive enough to respond to light touches.

Pharmacy 52

Pharmacy Production 52

Drug Patent Watch

DECEMBER 9, 2024

The Essence of Pharmacognosy: Nature’s Pharmacy Unveiled Imagine walking through a lush rainforest, surrounded by countless plant species. High-Throughput Screening: Modern Technology Meets Natural Products Advanced technologies now allow researchers to rapidly test thousands of natural compounds against specific disease targets.

Drugs 92

Drugs Drug Development Pharmaceuticals Production 92

Drug Channels

APRIL 1, 2025

For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. Click here to see the original post from January 2025.

Biosimilars 52

Biosimilars Pharmacy Production Drugs 52

Drug Channels

MARCH 4, 2025

for an exclusive deep dive into the latest trends, data, and strategies shaping the pharmacy benefit management (PBM) industry. Pharmacies and Pharmacy Benefit Managers , Dr. Fein will provide invaluable insights to help you and your team stay informed about this rapidly evolving market. Fein, Ph.D.,

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Fierce BioTech

DECEMBER 23, 2024

and often require consistent batches of drug product be administered to groups of research participants within a short timeframe, early phase studies present unique challenges for drug developers not typically experienced in later stages of development. First-in-Human, Drug-Drug Interaction, Food Effect, Bioequivalence, etc.),

Pharmacy 52

Pharmacy Trials Clinical Trials Clinical Development 52

The Pharma Data

JUNE 16, 2025

Lilly to Expand Access to Zepbound: All Approved Doses Now Available in Vials Through LillyDirect’s Self-Pay Pharmacy Solutions Eli Lilly and Company today made a significant announcement aimed at improving patient access to its obesity treatment Zepbound (tirzepatide). The company revealed that the highest approved Zepbound dosages — 12.5

Pharmacy 40

Pharmacy FDA Approval Treatment Disease 40

Perficient: Drug Development

FEBRUARY 11, 2025

This is crucial for understanding visual information, such as product images and instructional graphics. Increased Customer Loyalty : Customers who feel valued and respected are more likely to return and recommend the company’s products and services to others, leading to repeat business and a loyal customer base.

Pharmacy 52

Pharmacy Compliance Production Drugs 52

Drug Channels

OCTOBER 21, 2024

Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Is my organization haemorrhaging money to stay afloat with the shift to alternative distribution and pharmacy models?

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Marketing Compliance 98

Perficient: Drug Development

JANUARY 23, 2024

Is there anything worse than going to a pharmacy to pick up your prescriptions? Thankfully, many pharmacies have adopted home delivery services. Here are three ways pharmacies can adopt this Adobe Commerce solution to extend and secure trust with their patients. However, this presents some challenges.

Pharmacy 52

Pharmacy Doctors Production Science 52

Drug Channels

APRIL 24, 2024

See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. In DCI’s exclusive analysis below, we show that specialty pharmacies affiliated with pharmacy benefit managers (PBMs) play an outsized role in manufacturer-designated dispensing networks.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Production Drugs 52

Drug Channels

JUNE 18, 2024

See The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents. In DCI’s exclusive analysis below, we show that specialty pharmacies affiliated with pharmacy benefit managers (PBMs) play an outsized role in manufacturer-designated dispensing networks.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Drugs Production 52

FDA Law Blog: Biosimilars

AUGUST 21, 2023

Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ). 2, 2020 ( DOJ Press Release ).

Pharmacy 52

Pharmacy Regulations Production Laboratories 52

Drug Channels

SEPTEMBER 23, 2020

Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? Before the pandemic, specialty pharmacies—via white, brown, and clear bagging—had already displaced buy-and-bill distribution channels for a substantial chunk of provider-administered specialty drugs.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Drugs 52

Drug Channels

JULY 18, 2023

As I predicted in 2021 , some products launched with list prices that are only slightly lower than Humira’s list price, while others are trying to tempt payers and pharmacy benefit manages (PBMs) with deep list price discounts. This month, nine biosimilar versions of adalimumab launched in the U.S.

Biosimilars 98

Biosimilars Pharmacy Marketing Drugs 98

Drug Channels

DECEMBER 12, 2024

However, provider pushback has limited specialty pharmacies' share gains, so that buy-and-bill remains the most common channel for these products. Payers adoption of white baggingand providers push backreflect the ongoing battle for oncology margin in U.S. drug channels.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 52

Drug Channels

APRIL 16, 2021

To learn more about AssistRx’s technology solutions register for their Optimizing Program Performance: An Innovative Approach for Retail and Specialty Products webinar series. Read on for Jeff’s insights. Read more » Copyright © 2006-2021 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Production 52

Production Pharmacy Therapies Drugs 52

Drug Channels

DECEMBER 18, 2020

Will COVID-19 trigger long-term share gains for specialty pharmacies as suppliers to hospitals and physician offices? Before the pandemic, specialty pharmacies—via white, brown, and clear bagging—had already displaced buy-and-bill distribution channels for a substantial chunk of provider-administered specialty drugs.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Hospitals Drugs 52

Drug Channels

SEPTEMBER 2, 2020

I'm rerunning this post to provide context for manufacturers' recent actions regarding 340B contract pharmacies. Yesterday, Eli Lilly announced that its products can be dispensed only at covered entities and their child sites, but not via external pharmacies. per 3 mL pen or $0.10 per 10 mL vial.

Pharmacy 52

Pharmacy Government Hospitals Pharmaceuticals 52

Drug Channels

MARCH 28, 2023

This week, I’m rerunning some popular posts while I prepare for this Friday’s live video webinar: Discount Cards, Cost-Plus Pharmacies, and PBMs: Trends, Controversies, and Outlook. Each exclusion list now contains about 600 products. Click here to see the original post and comments from January 2023.

Biosimilars 98

Biosimilars Pharmacy Drugs Production 98

Drug Channels

MARCH 21, 2025

Greg discusses some of the challenges manufacturers face with product commercialization, patient access and adherence, and negotiating partnerships with pharmacy benefit managers (PBMs). Todays guest post comes from Greg Skalicky, President of EVERSANA.

Pharmacy 98

Pharmacy Production Drugs 98

Drug Channels

OCTOBER 3, 2023

As I predicted in 2021 , some products launched with list prices that are only slightly lower than Humira’s list price, while others are trying to tempt payers and pharmacy benefit managers (PBMs) with deep list price discounts. This month, nine biosimilar versions of adalimumab launched in the U.S.

Biosimilars 98

Biosimilars Pharmacy Marketing Pharmaceuticals 98

Drug Channels

JANUARY 27, 2023

Saket discusses market access and contracting strategies for medical benefit products when pharmacy benefit biosimilar therapies launch. Today’s guest post comes from Saket Patel, Consultant, Advisory Services at MMIT. He then describes how to automate formulary and medical policies to protect manufacturers from overpayment.

Biosimilars 97

Biosimilars Pharmacy Therapies Production 97

Drug Channels

MARCH 5, 2024

WHAT YOU WILL LEARN In 2023, the Inflation Reduction Act of 2022 (IRA) began to alter the Medicare Part D program and trigger changes in beneficiary out-of-pocket spending, drug prices, pharmacy economics, and market access strategies. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 98

Pharmacy Drugs Biosimilars Marketing 98

Drug Channels

JUNE 9, 2023

Today’s guest post comes from Kristina Crockett, VP, Product Management at CoverMyMeds. Kristina shares the story of Shanette, a single mother who faced sticker shock at the pharmacy counter. Kristina then explains how manufacturers can increase patient access and affordability with a comprehensive affordability strategy.

Pharmacy 98

Pharmacy Production Drugs 98

Perficient: Drug Development

APRIL 17, 2025

Creating operable content in pharmacies that minimizes the risk of mistakes and accommodates unintentional actions is crucial for accessibility. By applying this principle, pharmacies can design inclusive services that enhance customer confidence and usability.

Pharmacy 52

Pharmacy Production 52

The Pharma Data

JULY 29, 2021

Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus. Semglee (insulin glargine-yfgn) is the first interchangeable biosimilar product approved in the U.S.

Biosimilars 52

Biosimilars Production FDA Approval FDA 52

Perficient: Drug Development

APRIL 17, 2025

When designing operable digital and physical spaces in pharmacies, the principle of Equitable Use is foundational. By incorporating this principle into operable content, pharmacies can create environments that are truly inclusive, empowering all individuals to engage independently and effectively.

Pharmacy 52

Pharmacy Compliance Production 52

Drug Channels

OCTOBER 20, 2023

Today’s guest post comes from Melanie Christie, VP of Product Management at CoverMyMeds. Melanie discusses how the nationwide shortage of pharmacy technicians affects pharmacists.

Pharmacy 98

Pharmacy Treatment Production Drugs 98

Drug Channels

SEPTEMBER 22, 2023

Today’s guest post comes from Kristina Crockett, VP of Product Management at CoverMyMeds. In this article, Kristina reviews how brands can help patients make connections that address medication affordability challenges, whether at the prescriber’s office, the pharmacy, or at home. Read on for Kristina’s insights.

Pharmacy 98

Pharmacy Production Drugs 98

Drug Channels

SEPTEMBER 22, 2023

Today’s guest post comes from Kristina Crockett, VP of Product Management at CoverMyMeds. In this article, Kristina reviews how brands can help patients make connections that address medication affordability challenges, whether at the prescriber’s office, the pharmacy, or at home. Read on for Kristina’s insights.

Pharmacy 97

Pharmacy Production Drugs 97

Advarra

AUGUST 31, 2022

Institutional biosafety committees (IBCs) frequently receive questions about the proper methodology for preparing a syringe for transport from a drug room or pharmacy to the clinic where the injection will be administered. The post Safe Sharps Handling When Dispensing Investigational Products appeared first on Advarra.

Production 52

Production Engineering Pharmacy Virus 52

Drug Target Review

FEBRUARY 10, 2025

Over the years, Ive had the privilege of working on more than 25 different products, Bock shared. In this model, once a product is produced and delivered to the clinical pharmacy, the clinical team takes over the trial with little to no interaction with the manufacturing team.

Therapies 64

Therapies Treatment Engineering Clinical Trials 64